Snapshot from Aug 25, 2026 at 07:00 UTC. For live data and tracking: View Live

United Kingdom & Bleichmar Fonti & Auld LLP

2 shared events · Importance 3 · Last updated Jul 31, 2026

Importance
3
Shared Events
2
Actions
0
Sentiment
0
Live sentiment trends, interaction importance charts, and action volume tracking available on the Ergen Dashboard
24
Regulatory
United Kingdom: The United Kingdom's United Kingdom — National Health Service (NHS) was involved in the NHS-Galleri trial, which is central to the class action lawsuits against Illumina — Holy Grail, Inc.
Bleichmar Fonti & Auld LLP: Bleichmar Fonti & Auld LLP is one of the law firms that filed the class action lawsuit against Illumina — Holy Grail, representing investors.
Jun 05, 2026 · 315 articles
14
Regulatory
United Kingdom: The United Kingdom is where the NHS-Galleri trial was conducted. The trial's failure may have implications for UK cancer screening initiatives.
Bleichmar Fonti & Auld LLP: BFA filed a class action lawsuit against Illumina — Holy Grail and certain executives, alleging securities fraud related to the NHS-Galleri trial. The firm is actively soliciting investors to join the case.
Jun 09, 2026 · 192 articles
ERGEN INTELLIGENCE
Explore this relationship live

Track how United Kingdom and Bleichmar Fonti & Auld LLP interact across events, view sentiment trends, and discover connected entities.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.